Analystreport

Harrow (NASDAQ:HROW) had its "buy" rating reaffirmed by analysts at B. Riley.

Harrow Health, Inc.  (HROW) 
Last harrow health, inc. earnings: 11/13 04:21 pm Check Earnings Report